Substance Use Disorders (SUD)
5
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Treatment Research
9 treatments under study, led by Cvl936
Research Leaders
9 sponsors active, led by Karolinska Institutet
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
1 terminated out of 5 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Culturally Engaged REcovery: MOms Connected Through Native communitY
Group Activities to Support Addiction Recovery
Project COMET: Massed Prolonged Exposure for PTSD and SUD
A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT
Research Network
Common Treatments
- Cvl9361
- Assessment Only Of Alcohol And Drug Use1
- Multiple Modality1
- Cradleboard Journey1
- Escreen1
Active Sponsors
- Karolinska Institutet1
- Rutgers, The State University of New Jersey1
- University of California, San Diego1
- University of Minnesota1
- Cerevel Therapeutics, LLC1
Top Investigators
University of Nebraska
University of Utah
Karolinska Institutet
Cerevel Therapeutics, LLC
University of Utah
Related Conditions
- Trauma And Stressor Related Disorders1
- Addiction1
- Cultural Adaptation1
- Comorbidity1
- Posttraumatic Stress Disorder Ptsd1